Cypress Capital Management LLC Abbott Laboratories Transaction History

Cypress Capital Management LLC

$0
Q4 2022

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $6,095 - $7,057	-63 Reduced 0.1%	61,612 $5.96 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $31,743 - $38,368	-311 Reduced 0.5%	61,675 $6.7 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $90,189 - $109,980	-791 Reduced 1.26%	61,986 $7.34 Million
Q4 2021 Feb 22, 2022	SELL	$115.53 - $141.46 $31,077 - $38,052	-269 Reduced 0.43%	62,777 $8.84 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $7,193 - $8,468	-68 Reduced 0.11%	63,046 $7.31 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $14.4 Million - $17 Million	-132,471 Reduced 67.73%	63,114 $7.56 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $133,350 - $145,313	1,270 Added 0.65%	195,585 $21.4 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 0.05%	194,315 $21.1 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $151,761 - $194,236	-1,982 Reduced 1.01%	194,415 $17.8 Million
Q1 2020 Apr 24, 2020	SELL	$62.82 - $91.86 $355,184 - $519,376	-5,654 Reduced 2.8%	196,397 $15.5 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $138,805 - $154,523	-1,768 Reduced 0.87%	202,051 $17.6 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $4.9 Million - $5.32 Million	59,905 Added 41.63%	203,819 $17.1 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $4.34 Million - $5.06 Million	-59,505 Reduced 29.25%	143,914 $5.66 Million
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $291,520 - $340,000	4,000 Added 2.01%	203,419 $17.1 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $1.8 Million - $2.18 Million	-27,252 Reduced 12.02%	199,419 $15.9 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $253,586 - $287,276	-3,868 Reduced 1.68%	226,671 $16.4 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $162,909 - $196,531	-2,679 Reduced 1.15%	230,539 $16.9 Million
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $86,873 - $95,881	-1,509 Reduced 0.64%	233,218 $14.2 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $35,618 - $40,271	-633 Reduced 0.27%	234,727 $14.1 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $536 - $574	-10 Reduced -0.0%	235,360 $13.4 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $50,895 - $56,804	-1,059 Reduced 0.45%	235,370 $12.6 Million
Q2 2017 Aug 15, 2017	BUY	N/A	236,429	236,429 $11.5 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.2 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.76 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.5 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.08 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC with notifications on news.

Account